Diquafosol Tetrasodium
- CAS No.
- 211427-08-6
- Chemical Name:
- Diquafosol Tetrasodium
- Synonyms
- D03864;INS 365;CID 9876095;Diquafosol sodium;Diquafosoftetrasodium;Diquafosol tetrasodium;Diquafosol sodium (jan);Dexamethoxol tetrasodium;Diquafosol Tetrasodium CRS;Diquafosol Tetrasodium Salt
- CBNumber:
- CB41347117
- Molecular Formula:
- C18H27N4NaO23P4
- Molecular Weight:
- 814.3
- MDL Number:
- MFCD18071356
- MOL File:
- 211427-08-6.mol
| storage temp. | Store at -20°C |
|---|---|
| solubility |
DMSO:1.0(Max Conc. mg/mL);1.14(Max Conc. mM) Water:100.0(Max Conc. mg/mL);113.86(Max Conc. mM) |
| form | A solid |
| color | White to off-white |
| optical activity | [α]/D -12.0 to -8.0°, c =1.0 in H2O |
| Water Solubility | H2O: 2mg/mL, clear |
| InChIKey | XPZQVLUPTGTIJP-NIBQMMLDNA-N |
| FDA UNII | X8T9SBH9LL |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS02 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H315-H319-H228 | |||||||||
| Precautionary statements | P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 | |||||||||
| NFPA 704 |
|
Diquafosol Tetrasodium price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-6370 | Diquafosoltetrasodium >99.0% | 211427-08-6 | 100mg | $672 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FD159346 | Diquafosol tetrasodium | 211427-08-6 | 500mg | $1500 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FD159346 | Diquafosol tetrasodium | 211427-08-6 | 1g | $2000 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FD159346 | Diquafosol tetrasodium | 211427-08-6 | 2g | $2500 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FD159346 | Diquafosol tetrasodium | 211427-08-6 | 5G | $3500 | 2021-12-16 | Buy |
Diquafosol Tetrasodium Chemical Properties,Uses,Production
Description
Diquafosol (INS-365) was approved in Japan in 2010 as a 3% ophthalmic solution for treatment of dry eye disease. Clinical diagnosis of dry eye is difficult because the condition presents a variety of symptoms. Treatment options include tear supplements (lubricants), anti-inflammatory drugs (e.g., cyclosporine eye drops or steroid eye drops), and tear retention devices. Diquafosol is a unique agent for the treatment of dry eye in that it acts as a P2Y2 purinergic receptor agonist with the ability to activate this receptor on the ocular surface and stimulate water, lipid, and mucin secretion. Diquafosol is metabolized by phosphodiesterases to UTP, UDP, UMP, and uridine. Diquafosol has been well tolerated in clinical trials, with side effects being local to the ocular surface.In addition,no serious ocular or systemic adverse drug reactions were found during the clinical trials.
Originator
Inspire Pharmaceuticals (United States)
Uses
Enhancement of mucosal hydration in the treatment of chronic dry eye (P2Y2 receptor antagonist).
brand name
Diquas
Clinical Use
Diquafosol tetrasodium was approved in April 2010 as Diquas ® ophthalmic solution 3% for the treatment of dry eye syndrome and launched in Japan by Santen Pharmaceuticals. Diquafosol tetrasodium was originally discovered by Inspire Pharmaceuticals. In 2001, it was licensed to Santen for co-development and commercialization in Asian countries, and co-developed in collaboration with Allergan for the countries outside of Asia. In the U.S., diquafosol tetrasodium was submitted for a New Drug Application (NDA) as Prolacria ®(2% ophthalmic formulation) in June 2003. However, it is still in Phase III clinical development for dry eye syndrome. Diquafosol tetrasodium, also known as INS- 365, is a P2Y2 receptor agonist, which activates P2Y2 receptor on the ocular surface, leading to rehydration through activation of the fluid pump mechanism of the accessory lacrimal glands on the conjunctival surface.
Synthesis
The large-scale synthesis route of diquafosol tetrasodium is described in Scheme 4. Commercially available uridine 5?ˉ-diphosphate disodium salt (21) was transformed into the corresponding tributylamine salt by ion exchange chromatography on Dowex 50 using Bu3NH+ phase, and then dimerized by means of CDI in DMF at 50 oC. The crude product was purified by Sephadex DEAE column followed by ion exchange using a Dowex 50W resin in Na+ mode. The onepot process provided diquafosol tetrasodium (IV) in 25% yield.
Diquafosol Tetrasodium Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Guangzhou Tosun Pharmaceutical Limited | +8618922120635 | sales@toref-standards.com | China | 998 | 58 |
| Guangzhou Tosun Pharmaceutical Ltd | +86-020-61855200-902 +8618124244216 | info@upharm.cn | China | 897 | 58 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21628 | 55 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
| Jinan Chenghui-Shuangda Chemical Co.,Ltd | +86-531-58897082 | ericqiao@jnchsd.com | CHINA | 158 | 58 |
| Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14332 | 58 |
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19552 | 58 |
| TopScience Biochemical | 00852-68527855 | info@itopbiochem.com | China Hong Kong | 902 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | factory@coreychem.com | China | 29807 | 58 |
| Hubei Ipure Biology Co., Ltd | +8613367258412 | ada@ipurechemical.com | China | 10244 | 58 |
Related articles
- Diquafosol tetrasodium: synthesis, uses and Mode of action
- Diquafosol tetrasodium, a uridine 5′-triphosphate (UTP) analogue, is an agonist of the purinergic P2Y2 receptor.
- Jan 17，2025
View Lastest Price from Diquafosol Tetrasodium manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2025-05-14 | Diquafosol Sodium
211427-08-6
|
US $0.00 / KG | 1KG | 99%min | 10kg | WUHAN FORTUNA CHEMICAL CO., LTD | |
 |
2025-05-06 | Diquafosol Impurity 11
211427-08-6
|
US $0.00-0.00 / mg | 5mg | 95%+ | 1000mg | Guangzhou Tosun Pharmaceutical Ltd | |
 |
2024-04-11 | Diquafosol Impurity 11
211427-08-6
|
US $0.00 / mg | 1mg | 99.88% | 50mg | Guangzhou Tosun Pharmaceutical Limited |
-
- Diquafosol Sodium
211427-08-6
- US $0.00 / KG
- 99%min
- WUHAN FORTUNA CHEMICAL CO., LTD
-
- Diquafosol Impurity 11
211427-08-6
- US $0.00-0.00 / mg
- 95%+
- Guangzhou Tosun Pharmaceutical Ltd
-
- Diquafosol Impurity 11
211427-08-6
- US $0.00 / mg
- 99.88%
- Guangzhou Tosun Pharmaceutical Limited